BELGRADE, Mont.–(BUSINESS WIRE)–December 18, 2013– Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft materials and coatings for medical applications, today announced the appointment of OsTek Orthopaedics Inc. as a distributor of Bacterin’s proprietary biologic products in Canada.
Daniel Goldberger, Bacterin’s CEO, commented “We are pleased to have established this distribution agreement with OsTek. Ms. Woodside and her group of representatives are well respected in the Canadian market, and she contributes vast knowledge and experience as a biologics distributor. This relationship represents a significant opportunity for our products and will allow us to enter the Canadian market, expanding our business throughout North America. We anticipate that Bacterin products will be well received from coast to coast in Canadian markets based on OsTek’s distribution strengths and strong network of customers and surgeon relationships. Bacterin’s Biologic portfolio will complement OsTek’s existing orthopaedic business.”
Christina Woodside, founder and President of OsTek Orthopaedics, speaks positively of the venture. “We are more than impressed with Bacterin’s products and their professional approach to their relationship with the medical community. We are excited about Bacterin’s extensive product line and breadth of application in the Canadian Healthcare market. With the help and guidance of Bacterin’s knowledgeable marketing team, we have been successful in creating and training a sales team with coverage from coast to coast. Product introduction to Canadian surgeons has already begun.”
About Bacterin International Holdings
Bacterin International Holdings, Inc. (NYSE MKT: BONE) develops, manufactures and markets biologics products to domestic and international markets. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.
Bacterin’s Medical Device division develops, employs, and licenses coatings for various medical device applications. For further information, please visit www.bacterin.com.
About OsTek Orthopaedics
OsTek Othopaedics Inc. was founded in 2004 as the Canadian national distributor for MicroAire Surgical Power Instruments and has expanded into additional product offerings, including Bacterin Biologics. The company is owned and operated by Christina Woodside, who brings 22 years of hands-on Orthopaedic Industry experience, as the Canadian GM of Synthes Canada, and Smith & Nephew (Surgical) Inc, and works with numerous representatives throughout all Canadian provinces. OsTek operates a business model based on the need for fast turnaround of deliveries and response to individual customer needs.